NGS-Based Monitoring and Diagnostic Test Market, Global Outlook and Forecast 2023-2030
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
This report contains market size and forecasts of NGS-Based Monitoring and Diagnostic Test in Global, including the following market information:
Global NGS-Based Monitoring and Diagnostic Test Market Size 2024-2030, ($ millions)
The global NGS-Based Monitoring and Diagnostic Test market is projected to reach US$ million by 2029.
We has surveyed the NGS-Based Monitoring and Diagnostic Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NGS-Based Monitoring and Diagnostic Test Market, by Type, 2024-2030 ($ millions)
Global NGS-Based Monitoring and Diagnostic Test Market Segment Percentages, by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Global NGS-Based Monitoring and Diagnostic Test Market, by Application, 2024-2030 ($ millions)
Global NGS-Based Monitoring and Diagnostic Test Market Segment Percentages, by Application
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
Global NGS-Based Monitoring and Diagnostic Test Market, By Region and Country, 2024-2030 ($ Millions)
Global NGS-Based Monitoring and Diagnostic Test Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
